In Memoriam

In memoriam: Ulrich auf dem Keller

Swarnali  Roy
May 13, 2024

Ulrich auf dem Keller, a leader in wound healing research and mass spectrometry-based proteomics technology, died September 1, 2023 at the age of 49.

Ulrich auf dem Keller

Born on April 5, 1974 and raised in Mülheim an der Ruhr, Germany, auf dem Keller received his undergraduate diploma in biochemistry in 2000. He then joined ETH, Zurich in the biology department under the mentorship of Pfizer Academic Award winner Sabine Werner where he identified Nrf2 as a key player in the cellular stress response and studied Nrf-mediated gene expression in keratinocytes in the prevention of skin tumors. He obtained his Ph.D. in 2005. 

auf dem Keller moved to the Centre for Blood Research, Vancouver, Canada, in 2006 to join Christopher Overall’s lab where he quantified changes in the proteome and analyzed the nature of protein amino termini analysis (N-terminome) using iTRAQ-TAILS technology and showed that loss of a single protease could perturb the proteolytic signaling network and enhance inflammation. 

In 2009, auf dem Keller started an independent lab in ETH, Zurich as a senior scientist and group leader.  He exploited the capability of iTRAQ-TAILS to exploring the substrate degradome of matrix metalloproteinase and translated his research to address complex proteolytic activities in healing impairments. In 2017, he moved to the section of protein science and biotherapeutics at Technical University of Denmark Bioengineering in Lyngby as a professor. He continued there until his death, exploring the quantitative proteomics approach in complex biological matrices.

auf dem Keller had more than 150 publications with 6,587 citations to date. He received a Herbert Tabor Young Investigator Award in 2011 from the American Society for Biochemistry and Molecular Biology for his studies of proteolytic events in the skin. 

Colleagues remember auf dem Keller as a stellar scientist and a fantastic mentor and friend. He was instrumental in the overall growth of his department and his students. He spoke Latin and ancient Greek, had an interest in classical music and was an outstanding viola player. 

He is survived by his wife and two children.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Swarnali  Roy

Swarnali Roy is a postdoctoral researcher at the National Institute of Diabetes and Digestive and Kidney Diseases, NIH and an ASBMB Today volunteer contributor.

Related articles

In memoriam: Joel Habener
Jessica Desamero
In memoriam: Walter A. Shaw
Jessica Desamero

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Introducing STEM before self-doubt
Profile

Introducing STEM before self-doubt

March 26, 2026

With hair biology workshops and hands-on STEM programs, Shyretha Brown is building pathways for young girls to see themselves in science. Through Building Bridges, she blends education, identity and access to expand who feels welcome in STEM.

In memoriam: Richard Wolfenden
In Memoriam

In memoriam: Richard Wolfenden

March 23, 2026

He was an enzymologist whose work helped spur the development of ACE inhibitor drugs and has been an ASBMB member since 1967.

Tansey named department chair
Member News

Tansey named department chair

March 16, 2026

He has been a faculty member at Otterbein University since 2002.

In memoriam: Joel Habener
In Memoriam

In memoriam: Joel Habener

March 16, 2026

He discovered GLP-1, which helped pave the way for transformative diabetes and obesity therapies, and he was an ASBMB member for 25 years.

In memoriam: Walter A. Shaw
In Memoriam

In memoriam: Walter A. Shaw

March 9, 2026

He is the namesake for the Walter A. Shaw Young Investigator Award in Lipid Research and founded Avanti Polar Lipids.

Dorn named assistant professor
Member News

Dorn named assistant professor

March 9, 2026

She will open her lab at the University of Vermont in fall 2026, and her research will focus on catalysis, synthetic methodology and medicinal chemistry.